5-(2-Phenylethenyl)benzene-1,2,3,4-tetrol

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 5-(2-Phenylethenyl)benzene-1,2,3,4-tetrol
• 英文别名: 5-(2-phenylethenyl)benzene-1,2,3,4-tetrol
• 化学式: C₁₄H₁₂O₄
• 分子量: 244.24
• InChiKey: NSRKPHLHEMCETL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  80.9
• 氢给体数：
  4
• 氢受体数：
  4

文献信息

• Sirtuin polymorphisms and methods of use thereof
  申请人：Laakso Markku

  公开号：US20080249103A1

  公开（公告）日：2008-10-09

  Provided herein are methods for diagnosis and prognosis using polymorphic variants of sirtuins. Such polymorphic may be used, for example, to identify subjects that would be responsive to treatment with a sirtuin modulating compound and/or subjects that are suffering from or susceptible to a disease mediated by a sirtuin. Also provided are methods for determining the predictive value of a sirtuin polymorphic variant, methods for evaluating sirtuin modulating compounds, and methods for determining appropriate dosage and/or treatment regimens for subjects having one or more sirtuin polymorphic variants. Screening methods for identifying sirtuin modulating compounds using polymorphic variants of a sirtuin are also provided.

  本文提供了使用sirtuins的多态性变体进行诊断和预后的方法。这种多态性可能被用来识别对sirtuin调节化合物治疗有响应的受试者，以及患有或易受sirtuin介导疾病影响的受试者。还提供了确定sirtuin多态性变体预测价值的方法，评估sirtuin调节化合物的方法，以及确定具有一个或多个sirtuin多态性变体的受试者的适当剂量和/或治疗方案的方法。还提供了使用sirtuin的多态性变体筛选识别sirtuin调节化合物的筛选方法。
• BIOMARKERS OF SIRTUIN ACTIVITY AND METHODS OF USE THEREOF
  申请人：Boss Olivier

  公开号：US20100215632A1

  公开（公告）日：2010-08-26

  Provided are methods for monitoring sirtuin modulation in a subject, for example, during therapeutic treatment with a sirtuin modulating compound. The methods involve determining the expression level of one or more sirtuin biomarkers in a biological sample from the subject. Also provided are methods for identifying compounds that modulate the activity of a sirtuin protein using one or more sirtuin biomarkers.

  提供了一种监测主体中sirtuin调节的方法，例如，在使用sirtuin调节化合物进行治疗期间。该方法涉及确定来自主体生物样本中一个或多个sirtuin生物标志物的表达水平。还提供了一种使用一个或多个sirtuin生物标志物识别调节sirtuin蛋白活性的化合物的方法。
• [EN] S-TRIAZINE COMPOUNDS CONTAINING ONE AMINOSILOXANE GROUP AND TWO PARTICULAR PARA-AMINOBENZALMALONATE GROUPS; COSMETIC COMPOSITIONS CONTAINING SAID DERIVATIVES; USES OF SAID S-TRIAZINE DERIVATIVES<br/>[FR] COMPOSÉS DE S-TRIAZINE CONTENANT UN GROUPE AMINOSILOXANE ET DEUX GROUPES PARA-AMINOBENZALMALONATE PARTICULIERS ; COMPOSITIONS COSMÉTIQUES CONTENANT LESDITS DÉRIVÉS ; UTILISATIONS DESDITS DÉRIVÉS DE S-TRIAZINE
  申请人：OREAL

  公开号：WO2009074409A1

  公开（公告）日：2009-06-18

  The invention concerns novel s-triazine compounds containing one aminosiloxane group and two particular para-aminobenzalmalonate groups. The invention also concerns cosmetic or dermatological compositions intended for the photoprotection of keratinous materials, comprising at least one s-triazine compound containing one aminosiloxane group and two particular grafted para-aminobenzalmalonate groups in a cosmetically acceptable medium. The invention also concerns the use of at least one s-triazine compound containing one aminosiloxane group and two particular grafted para-aminobenzalmalonate groups in a cosmetic composition, as an agent for filtering for UV-A radiation.

  这项发明涉及含有一个氨基硅氧烷基团和两个特定对氨基苯甲酸马隆酸酯基团的新型s-三嗪化合物。该发明还涉及用于角蛋白材料的光保护的化妆品或皮肤科学组合物，包括至少一种在化妆品可接受介质中含有一个氨基硅氧烷基团和两个特定嵌合对氨基苯甲酸马隆酸酯基团的s-三嗪化合物。该发明还涉及在化妆品组合物中使用至少一种含有一个氨基硅氧烷基团和两个特定嵌合对氨基苯甲酸马隆酸酯基团的s-三嗪化合物作为紫外线A辐射过滤剂的用途。
• Compositions for manipulating the lifespan and stress response of cells and organisms
  申请人：Sinclair A. David

  公开号：US20050096256A1

  公开（公告）日：2005-05-05

  Provided herein are methods and compositions for modulating the activity of sirtuin deacetylase protein family members; p53 activity; apoptosis; lifespan and sensitivity to stress of cells and organisms. Exemplary methods comprise contacting a cell with an activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as a sphingolipid, e.g., sphingosine.

  本文提供了调节sirtuin脱乙酰化酶蛋白家族成员、p53活性、细胞和生物的凋亡、寿命和对压力的敏感性的方法和组合物。示例方法包括将激活化合物（如黄酮类、stilbene、黄烷酮、异黄酮、儿茶素、查尔酮、单宁或花青素）或抑制化合物（如鞘脂类，例如鞘氨醇）与细胞接触。
• Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
  申请人：Sinclair A. David

  公开号：US20060025337A1

  公开（公告）日：2006-02-02

  Provided herein are methods and compositions for modulating the activity of sirtuin deacetylase protein family members; p53 activity; apoptosis; lifespan and sensitivity to stress of cells and organisms. Exemplary methods comprise contacting a cell with an activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as a sphingolipid, e.g., sphingosine. Also disclosed herein are methods for treating, preventing or diagnosing a disease associated with neuronal cell death, e.g., a neurodegenerative disease.

  本文提供了调节sirtuin去乙酰化酶蛋白家族成员、p53活性、细胞和生物的凋亡、寿命和对压力的敏感性的方法和组合物。举例来说，方法包括使用激活化合物（如黄酮类、苯乙烯类、黄酮酮类、异黄酮类、儿茶素、查尔酮、单宁或花青素）或抑制化合物（如鞘脂类，例如鞘氨醇）与细胞接触。本文还公开了治疗、预防或诊断与神经元细胞死亡相关的疾病（例如神经退行性疾病）的方法。